UK provides Pfizer vaccine for ages 12 and up

The UK will provide the Pfizer-BioNTechCCP (Chinese Communist Party) virus vaccine to several groups of children over the age of 12, said Health Minister Sajid Javid on Monday.

The Joint Committee on Vaccination and Immunization (JCVI), a government advisory body, issued a recommendation on Monday, advising children who are “at high risk for serious COVID-19 disease” to be vaccinated.

The Pfizer-BioNTech vaccine is currently the only CCP virus vaccine approved for use in children over the age of 12.

The group JCVI was recommended to vaccinate is children aged 12 to 15 years with severe neuropathy, Down’s syndrome, immunosuppression, and multiple or severe learning disabilities.

Children between the ages of 16 and 17 with underlying health are already vaccinated based on existing recommendations.

JCVI also recommended vaccination of children aged 12 to 17 years if they live with immunosuppressed individuals. The same is true for young adults who are likely to turn 18 in 3 months, “to ensure that they have a newly reborn 18-year-old child.”

The Commission said clinical trials in the United States suggest that side effects in children aged 12 to 15 are “generally short-lived, mild to moderate.”

Currently, the actual safety data for the COVID-19 vaccine in children is limited, adding that “the emergency of myocarditis (inflammation of the muscles of the heart) and pericarditis (inflammation of the membrane around the heart)” There are rare reports of Pfizer-BioNTech and Moderna vaccine use in millions of young adults. “

JCVI currently has the view that “the minimum health benefits of providing a universal COVID-19 vaccination to children do not outweigh the potential risks,” said Javid. “We will continue to review new data and consider whether to recommend vaccination,” JCVI said. Under 18 years of age without underlying health status in the future. “

As of March this year, less than 30 children died from COVID-19 in the UK, according to office data.

After reviewing all currently available information, the WHO Global Advisory Board on Vaccine Safety (GACVS), despite evidence suggesting a possible link between heart inflammation and emergency use mRNA vaccines, The benefits of the vaccine continue to be myocarditis and pericarditis in individuals.

However, some scientific experts say that more safety data is needed in a hurry to vaccinate children with the COVID-19 vaccine.

Russell Weiner, a professor of adolescent health at the Great Ormond Street Child Health Institute at University College London, Opinion piece Public health officials, listed in The Guardian, must wait until they have sufficient safety data before injecting them with the COVID-19 vaccine.

Dr. Robert Malone, the inventor of mRNA vaccine technology, said the risk-benefit ratio for children to be vaccinated “doesn’t look very good.”

Meiling Lee contributed to this report.

Posted on